Has Traditional Call Planning Passed Its Prime?
This paper explores simple and more complex additions and solutions to a myriad of issues facing future changes to call planning. A central theme in all the proposed solutions is t ...
Future Of Pharma: Evolving Commercial Models – Part 1
The pharmaceutical industry is in a state of flux with the increasing influence of payers, pressure from the government with restricted healthcare budgets, and the rise of multi-ch ...
Proposed Rule To End Rebates To PBMs For Medicare And Medicaid Programs
This white paper looks at how rebates to PBMs relate to drug prices from two perspectives: how they are supposed to work versus what actually happens. ...
Growing Attention Being Paid To Pharma Company Rebates And Discounts
Pharma companies need to better understand how to manage rebates and discounts, while also developing a broader view of the effect on patients and the healthcare system. ...
Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US
This white paper explores the unique challenges of ODs for RDs and the different approaches needed to address specific questions for their successful commercialization that vary fr ...
Perspectives On Pharma Company Use Of Open Payments Data
This paper provides a detailed analysis on the role and effects of “Sunshine Laws” and payments made to providers as seen from published empirical evidence, intricacies and cha ...
How Regulatory Changes Are Driving The Future Of The Medical Device Industry
With new entrants from emerging countries giving the established brands a run for their money, the medical device market has become more competitive. ...
How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?
The 2018 Congressional midterm elections are over after a bitter political fight. The voters have spoken. We are back to divided government, with Democrats controlling the House, a ...
Is The CVS-Aetna Merger A Pharma Industry Transformative Event?
US antitrust officials recently approved the proposed $69 billion CVS-Aetna merger. This merger follows a similar action taken by the Justice Department to approve the Cigna-Expres ...
As the coronavirus (COVID-19) global pandemic unfolds, we would like to share our plans to conduct our business seamlessly while giving utmost priority to the health and well-being of our employees and our ecosystem of customers, vendors, and partners.
Our hearts go out to anyone directly or indirectly impacted by this pandemic. We are inspired by the selfless service of healthcare workers, first responders, and other professionals who continue to serve the people in need.
Our two main priorities at Axtria include:
We pride ourselves on being a highly customer-centric company. Rest assured, we will continue to help achieve all business goals by ensuring that our team is fully equipped to stand in support. Our integrated cloud platforms enable global commercial organizations to work seamlessly and automate manual processes. They are built from the ground up to support teams that need to work remotely.
To ensure health and safety, we have asked our employees globally to follow the guidelines of the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and maintain social distancing, work from home, and swap in-person meetings with phone and video calls. Assuredly, our employees are well-versed in remote work, given our technology infrastructure, ongoing training, and existing processes. We have also rescheduled all in-person events in the coming weeks to digital platforms. Doing so allows us to suspend all unnecessary business travel and large gatherings.
Lastly, we will continue monitoring the COVID-19 data and will make operational adjustments as needed. As a data analytics company, we are committed to making data-driven decisions in every aspect of the business. We shall continue doing so using the most reliable data - from the WHO, the CDC, data-based case tracking via Johns Hopkins University (JHU), as well as through national and local administrations.
As always, Axtria will continue to provide our unwavering support. In dealing with the present circumstances, we will continue employing every effort to deliver uninterrupted services.
Further, you can bank on us to alert you of any protocol changes while encouraging you to approach us with your feedback and queries – not just as business partners, but as valued friends.
On behalf of all Axtrians, I wish you and your families safety and good health during these trying times.
We are isolated but united!
All the best,